O001/#504 Durvalumab, in combination with and following chemoradiotherapy, in locally advanced cervical cancer: results from the phase 3 international, randomized, double-blind, placebo-controlled calla trial

Bradley J. Monk, Jyoti Mayadev, Xiaohua Wu et al.|International Journal of Gynecological Cancer|2022

Cited by 15